![Sven Klussmann](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sven Klussmann
Direttore Tecnico/Scientifico/R&S presso NOXXON Pharma AG
Profilo
Sven Klussmann was the founder of TME Pharma NV, which was founded in 1997, where he held the title of Chief Scientific Officer.
Currently, he is the Chief Scientific Officer at NOXXON Pharma AG since 1997.
Dr. Klussmann's education includes an undergraduate degree from Freie Universität Berlin.
Posizioni attive di Sven Klussmann
Società | Posizione | Inizio |
---|---|---|
NOXXON Pharma AG
![]() NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | Direttore Tecnico/Scientifico/R&S | 01/01/1997 |
Precedenti posizioni note di Sven Klussmann
Società | Posizione | Fine |
---|---|---|
TME PHARMA N.V. | Fondatore | - |
Formazione di Sven Klussmann
Freie Universität Berlin | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
TME PHARMA N.V. | Health Technology |
Aziende private | 1 |
---|---|
NOXXON Pharma AG
![]() NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | Health Technology |
- Borsa valori
- Insiders
- Sven Klussmann